These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 1282635)

  • 21. Pharmacological interference with the cardiac renin-angiotensin system.
    Becker RH; Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S10-5. PubMed ID: 2483422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
    Martorana PA; Schölkens BA
    Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.
    Linz W; Wiemer G; Schölkens BA
    Am J Cardiol; 1997 Aug; 80(3A):118A-123A. PubMed ID: 9293964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
    Linz W; Gohlke P; Unger T; Schölkens BA
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
    Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W; Wiemer G; Schölkens BA
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption.
    Zhang X; Xie YW; Nasjletti A; Xu X; Wolin MS; Hintze TH
    Circulation; 1997 Jan; 95(1):176-82. PubMed ID: 8994434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors.
    Schrör K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S68-73. PubMed ID: 1282633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
    Farhy RD; Carretero OA; Ho KL; Scicli AG
    Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.